Photocall of the merger between drug companies Glaxo Wellcome and SmithKline Beecham, in London. L-R: Sir Richard Sykes and Jean-Pierre Garnier. The agreed deal will create the world's largest pharmaceuticals group. * Sir Richard Sykes is Chairman of Glaxo Wellcome / Non-Executive Chairman of merged company, and Jean-Pierre Garnier is Chief Executive elect of SmithKline Beecham / Chief Executive of proposed merged company. The merger will create a company with a value of around 114 billion which will be one of Europe's largest by stock market value. 19/05/03 Shareholders were, expected to r
Image details
Contributor:
PA Images / Alamy Stock PhotoImage ID:
2D30K27File size:
5 MB (139.8 KB Compressed download)Releases:
Model - no | Property - noDo I need a release?Dimensions:
1636 x 1062 px | 27.7 x 18 cm | 10.9 x 7.1 inches | 150dpiDate taken:
17 January 2000Photographer:
Andrew StuartMore information:
This image could have imperfections as it’s either historical or reportage.
Photocall of the merger between drug companies Glaxo Wellcome and SmithKline Beecham, in London. L-R: Sir Richard Sykes and Jean-Pierre Garnier. The agreed deal will create the world's largest pharmaceuticals group. * Sir Richard Sykes is Chairman of Glaxo Wellcome / Non-Executive Chairman of merged company, and Jean-Pierre Garnier is Chief Executive elect of SmithKline Beecham / Chief Executive of proposed merged company. The merger will create a company with a value of around 114 billion which will be one of Europe's largest by stock market value. 19/05/03 Shareholders were, expected to revolt over "fat cat" pay at GlaxoSmithKline's annual general meeting today. Mr Garnier, the firm's chief executive, was expecting criticism over his contract.